(Q44297631)

1 December 2017

title

Low density lipoprotein particles are small in patients with coronary vasospasm (English)

1 reference

1 December 2017

1 reference

Kunihisa Miwa

1

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

International Journal of Cardiology

1 December 2017

published in

1 reference

1 December 2017

volume

87

1 reference

1 December 2017

issue

2-3

1 reference

1 December 2017

page(s)

193-201

1 reference

"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

High‐density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Cigarette smoking is a major risk factor for coronary spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Vitamin E deficiency in variant angina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Comparative sensitivity of intracoronary injection of acetylcholine for the induction of coronary spasm in patients with various types of angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Detection of the "midband" lipoprotein in patients with coronary artery spasm.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Small LDL, atherogenic dyslipidemia, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

High-density lipoprotein particles are large in patients with variant angina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900250-4

7 January 2021

10.1016/S0167-5273(02)00250-4

Identifiers

DOI

1 reference

1 December 2017

1 reference